BMO Capital Maintains Outperform on Corteva, Lowers Price Target to $64
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst Joel Jackson has maintained an 'Outperform' rating on Corteva (NYSE:CTVA) but lowered the price target from $70 to $64.
October 30, 2023 | 2:40 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Corteva's price target has been lowered from $70 to $64 by BMO Capital, though the 'Outperform' rating is maintained.
The lowering of the price target by BMO Capital could potentially create a negative sentiment among investors, which might put downward pressure on the stock price in the short term. However, the maintained 'Outperform' rating indicates that the analyst still sees potential upside for the stock, which could counterbalance the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100